AREXVY

Google image searchProduct monograph

Active ingredient

respiratory syncytial virus prefusion f protein (rsvpref3), 120 MCG/0.5 ML

DIN: 02540207

Dosage form(s): POWDER FOR SUSPENSION

Route(s) of administration: INTRAMUSCULAR

Schedule: Schedule D

Company: GLAXOSMITHKLINE INC

Date: 06-SEP-2023

ATC:

• J07 — VACCINES (ATC, ATC/DDD, )
• J07B — VIRAL VACCINES (ATC, ATC/DDD)
• J07BX — Other viral vaccines (ATC, ATC/DDD)
• J07BX05 — RESPIRATORY SYNCYTIAL VIRUS VACCINE (ATC/DDD)

Pharmaceutical standard: USP

External Links for Arexvy

Search on Google

• Arexvy side effects
• Arexvy dosage
• respiratory syncytial virus prefusion f protein side effects
• respiratory syncytial virus prefusion f protein dosage

Glaxosmithkline Inc

Go to GlaxoSmithKline website to see drug product details. Sometimes you can find arexvy photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.